Neonatal congenital heart disease (CHD) is associated with altered cerebral hemodynamics and increased risk of brain injury. Two novel noninvasive techniques, magnetic resonance imaging (MRI) and diffuse optical and correlation spectroscopies (diffuse optical spectroscopy (DOS), diffuse correlation spectroscopy (DCS)), were employed to quantify cerebral blood flow (CBF) and oxygen metabolism (CMRO 2 ) of 32 anesthetized CHD neonates at rest and during hypercapnia. Cerebral venous oxygen saturation (S v O 2 ) and CBF were measured simultaneously with MRI in the superior sagittal sinus, yielding global oxygen extraction fraction (OEF) and global CMRO 2 in physiologic units. In addition, microvascular tissue oxygenation (StO 2 ) and indices of microvascular CBF (BFI) and CMRO 2 (CMRO 2i ) in the frontal cortex were determined by DOS/DCS. Median resting-state MRI-measured OEF, CBF, and CMRO 2 were 0.38, 9.7 mL/minute per 100 g and 0.52 mL O 2 /minute per 100 g, respectively. These CBF and CMRO 2 values are lower than literature reports for healthy term neonates (which are sparse and quantified using different methods) and resemble values reported for premature infants. Keywords: cerebral blood flow; cerebral hemodynamics; diffuse optics; MRI; near-infrared spectroscopy; neonatal ischemia INTRODUCTION Congenital heart disease (CHD) affects B35,000 neonates each year in the United States. These patients suffer both short-and long-term neurologic sequelae. Periventricular leukomalacia is the most common cerebral injury found in this population. This type of injury is characterized by focal necrosis in the periventricular white matter, and it is associated with pyknotic glial nuclei and reactive gliosis.
INTRODUCTION
Congenital heart disease (CHD) affects B35,000 neonates each year in the United States. These patients suffer both short-and long-term neurologic sequelae. Periventricular leukomalacia is the most common cerebral injury found in this population. This type of injury is characterized by focal necrosis in the periventricular white matter, and it is associated with pyknotic glial nuclei and reactive gliosis. 1, 2 During the early stages of brain development, the oligodendrocyte (brain glial cells) precursors are metabolically very active and highly susceptible to injury from reduced blood flow and oxygen delivery. Hence, hypoxiaischemia has been implicated as a major cause of this injury in CHD neonates.
Periventricular leukomalacia leads to impaired myelination and has been linked to worse neurodevelopmental outcomes in premature infants and postulated to cause (at least in part) the impaired cognition and cerebral palsy commonly seen in this cohort of infants with CHD. 3, 4 Quantification of the hemodynamic and metabolic state of these neonates via measurements of cerebral blood flow (CBF) and the cerebral metabolic rate of oxygen consumption (CMRO 2 ) should provide valuable information toward understanding the interaction between cardiac pathophysiology and subsequent cerebral health. Potentially, such new knowledge could help predict and prevent adverse outcomes.
Currently, few noninvasive diagnostic modalities exist for the study of cerebral hemodynamics and metabolism. Commercially available near-infrared spectroscopy devices are being used for assessing microvascular oxygen saturation in some cardiac intensive care units. Their major advantage is the ease of acquisition and capability for continuous bedside monitoring. Nevertheless, although near-infrared spectroscopy measurements of blood oxygen saturation have been used to infer cerebral perfusion and metabolism, the method's utility requires further evaluation. Transcranial Doppler ultrasound has also been used in this clinical population. 5 The method measures blood velocity in feeder arteries, which is difficult because of the small size of the vessels in neonates 6 and because the measurements are highly operator dependent.
Licht et al 7 applied arterial spin labeling (ASL) magnetic resonance imaging (MRI) to measure CBF in neonates. The method provides perfusion maps of the brain but is hampered by the extremely low CBF in this population. Alternatively, phase-contrast (PC) MRI yields velocity measurements in the major feeder or drainage vessels and therefore provides global CBF even for low-flow velocities. This method is well validated and has been used to study flow for more than 2 decades. 8 However, while quantification of total brain blood flow is relatively straightforward, measurement of cerebral venous oxygen saturation (S v O 2 ), the other key component required to quantify CMRO 2 , is not. Two different approaches have emerged to address the quantification of S v O 2 , both making use of the venous blood's paramagnetism: (1) Transverse relaxationbased methods (for example, T 2 Relaxation Under Spin Tagging TRUST, 9 and Quantitative Imaging of Extraction of Oxygen and Tissue Consumption, QUIXOTIC 10 ), and (2) susceptometric techniques that quantify the blood's magnetic susceptibility, which is linearly related to deoxyhemoglobin concentration [11] [12] [13] (for example phase-based measurement of regional oxygen concentration, PROM 14 ) . In this study, we employed recently developed MRI and optical methods for quantification of CBF and oxygen metabolism (CMRO 2 ). The MRI method measures venous blood oxygen saturation in the superior sagittal sinus (SSS) via MRI susceptometry [11] [12] [13] and, simultaneously, CBF by PC MRI; the combination yields global CMRO 2 in absolute physiologic units. The optical method utilizes a portable bedside instrument to probe regional microvascular tissue oxygenation, perfusion, and metabolism in the frontal cortex. 15 The primary aim was to quantify CBF, oxygen extraction fraction (OEF), and CMRO 2 at rest and in response to hypercapnia in a cohort of CHD neonates at risk for perinatal hypoxic-ischemic injury by means of concurrent measurements, with MRI and optical techniques. Further, we aimed to derive calibration factors to convert optical indices of cerebral hemodynamic variables into absolute units for this population group on the basis of the measures obtained by global MRI quantification of blood flow and CMRO 2 .
MATERIALS AND METHODS
All full-term newborn infants with complex CHD admitted to The Children's Hospital of Philadelphia were screened for participation in this study (approved by the Institutional Review Board, which adheres to the regulations of the Common Rule and the Food and Drug Administration's Institutional Review Board and human subject regulations). Inclusion criteria included gestational age of 40 ± 4 weeks and an intention to undergo surgery with cardiopulmonary bypass during the first month of life. Exclusion criteria included the following: small for gestational age (o2 kg), a history of neonatal depression (5 minutes Apgar scoreo5 or umbilical cord pHo7.0), or evidence of other end-organ dysfunction. In addition, subjects who experienced preoperative cardiac arrest requiring chest compressions were excluded from the study.
On the morning of the patient's scheduled cardiac surgery, the patient was anesthetized with 5 to 10 mg/kg of fentanyl, paralyzed with 0.2 mg/kg of pancuronium, and prepared for surgery, including nasotracheal intubation, and arterial line placement. The study protocol has been described previously 15, 16 and the timeline is illustrated in Figure 1 . Briefly, once the anesthetized and paralyzed patient was stabilized and baseline DOS measurements were made while obtaining vascular access, patients were brought to the MRI scanner where a second MRI-compatible, noninvasive optical probe was placed on the forehead for continuous DOS/ DCS monitoring. After a 15-minute baseline stabilization period of room air ventilation and an arterial blood gas documenting a partial pressure of carbon dioxide of 40 ± 4 mm Hg, MRI was performed to yield S v O 2 and CBF, from which CMRO 2 could be derived. Carbon dioxide was then added to the room air mixture to achieve a fraction of inspired CO 2 of B3% for a 30-minute hypercapnic period to permit gas equilibration. Magnetic resonance imaging and DOS/DCS data were acquired simultaneously at the end of this 30-minute hypercapnic period. During the period of equilibration, an anatomic and volumetric brain MRI was obtained.
Heart rate, cuff blood pressure, peripheral oxygen saturation, and fraction of inspired CO 2 were monitored and recorded throughout the duration of the study. Arterial blood samples obtained at the start of the baseline period and at the end of the hypercapnia period were used to document that the desired conditions were achieved and to assess arterial oxygen saturation (SaO 2 ) and hemoglobin (Hb) concentration. Blood samples were analyzed using an i-STAT handheld blood analyzer for partial pressure of carbon dioxide (Abbott Laboratories, Princeton, NJ, USA) and an AVOXimeter 1000E co-oximeter for SaO 2 and Hb (A-VOX Systems, San Antonio, TX, USA).
Magnetic Resonance Imaging Measurements
Cerebral venous oxygen saturation quantification via MR susceptometry relies on the relative magnetic susceptibility difference, Dw, between intravascular blood in the SSS and surrounding tissue. This susceptibility difference is a function of blood oxygenation level causing a perturbation in the local magnetic field; with intravascular water protons sensing a slightly larger magnetic field than those in the surrounding tissue. These magnetic field shifts, and hence the oxygenation level of blood, can be quantified by measuring the phase (f)of the MRI signal. For quantification of S v O 2 the vessel of interest, i.e., the sagittal sinus, is modeled as a long paramagnetic cylinder 11, 12 and S v O 2 is determined as
where g is the gyromagnetic ratio of water protons (42.576 MHz/T), Df is the average phase difference between intravascular blood and surrounding tissue, Hct is the blood hematocrit, and y is the tilt angle of the vessel with respect to the main field, B o . Df is given as
Here, DB is the incremental field inside the vessel relative to that of the adjacent tissue, and DTE is the inter-echo spacing between two gradient-recalled echoes. Dw do is the susceptibility difference in p.p.m.
(SI units) between fully deoxygenated and oxygenated erythrocytes. 17 Total CBF was quantified by PC MRI, 8 a standard technique for measuring blood flow velocity in the SSS, from which CBF was calculated by multiplying average velocity in the vessel by the cross-sectional area. As the SSS is known to drain 45% of the total brain blood volume, 18, 19 it is Subsequently, the patient was placed in the magnet first inhaling room air for 15 minutes; followed by addition of CO 2 to the gas mixture (fraction of inspired CO 2 , 3%). Diffuse optical spectroscopy and diffuse correlation spectroscopy (DCS) data were acquired continuously in-magnet over this entire time period. Oximetry and phase-contrast MRI scans (1 minute in duration) were taken in-magnet at baseline and during hypercapnia. Arterial blood gases (ABG) were also obtained during room air and hypercapnia conditions. PC, phase-contrast. 
where C a is the arterial oxygen concentration in mL O 2 /dL blood) and was determined in each subject as C a ¼ 1.39 Â S a O 2 Â Hgb, and OEF is the oxygen extraction fraction. S a O 2 and Hb were determined from arterial blood samples. Oxygen extraction fraction was calculated as
Magnetic Resonance Imaging Protocol
All images were acquired on a 1.5T Avanto MRI system (Siemens Medical Systems, Malvern, NJ, USA) using a 12-channel head coil. An axial gradientecho localizer scan was used to choose the straightest section of the vessel of interest (SSS) and to estimate the tilt angle y of the SSS with respect to B 0 from the coordinates of the centroid of the vessel at two axial locations. A gradient-echo pulse sequence was used for simultaneous measurement of S v O 2 and CBF in the SSS. Specifically, S v O 2 was quantified using MRI susceptometry-based oximetry and CBF via PC MRI. Details on the pulse sequence are in Jain et al.
13,20
The scan parameters were as follows: voxel size Anatomic T 1 -and T 2 -weighted high-resolution MRI was performed and neonatal brain volumes were estimated from the resulting images using standard segmentation techniques to obtain CBF and CMRO 2 in conventional units of mL/minute per 100 g and mL O 2 /100 g per minute, respectively.
Relative change in CBF (%DCBF) due to hypercapnia was quantified as a ratio, i.e.,
where the subscript indicates data acquired during the hypercapnic (CO 2 ) or room air breathing conditions in-magnet. Similar formulas were used to quantify relative changes in OEF (i.e., %DOEF) and CMRO 2 (i.e., %DCMRO 2 ). Change in S v O 2 was quantified as the difference between hypercapnic and room air values.
Diffuse Optical and Diffuse Correlation Spectroscopy DOS and DCS, respectively use near-infrared light to noninvasively probe static and dynamic optical properties of cortical brain tissue microvasculature. These techniques are described in Durduran et al. 21 and the specific protocol and measurement details for the present study is detailed in references 15, 16 and in Appendix 1. In brief, frequency-domain DOS enables quantification of absolute regional (microvascular) cerebral oxy-and deoxy-hemoglobin concentration (HbO 2 and HbR, respectively, in mmol/L) using photon diffusion theory 21 From this information, total Hb concentration (THC ¼ HbO 2 þ HbR, in mmol/L), microvascular tissue oxygenation (StO 2 ¼ HbO 2 /THC Â 100%), OEF, and cerebral blood volume (CBV, in mL/ 100 g) 22 are readily derived (see Appendix 1). Diffuse correlation spectroscopy monitors regional microvascular CBF noninvasively without the use of exogenous tracers. 21, 23 Diffuse correlation spectroscopy quantifies temporal fluctuations in reflected light intensity at points on the tissue surface, which are primarily caused by moving red blood cells. 21 A tissue blood flow index (BFI, cm 2 /second) is derived from these temporal fluctuations. Previous studies have shown that changes of BFI relative to a baseline are strongly correlated with changes in CBF relative to baseline values measured by other CBF techniques. 15, 21, 24 Diffuse Optical Spectroscopy and Diffuse Correlation Spectroscopy Instrumentation and Study Protocol A schematic of the measurement protocol is provided in Figure 1 , and further details are given in Appendix 1. First, baseline DOS measurements of absolute tissue physiologic parameters, i.e., HbR, HbO 2 , THC, and StO 2 were made on the patient's forehead while the subject was sedated, stabilized, and while vascular access was obtained outside the MRI scanner. 16 Next, the patient was placed in the MRI scanner; continuous (0.13 Hz) DCS measurements of tissue BFI as well as DOS measurements of changes in HbO 2 and HbR with respect to preMRI values were made by a separate optical probe that employed a single source-detector separation at 2.5 cm as described in Durduran et al and Buckley et al 15, 24 (see Figure 2 for sample time series of DOS data obtained in the MRI scanner). For comparison with the MRI data and to assess the effects of hypercapnia, mean values of all parameters were calculated for each patient by averaging these parameters during the B1-minute room-air and hypercapnia MRI scans. Absolute hypercapnic CBV, OEF, and StO 2 were also quantified (see Appendix 1).
Finally, DOS-based measurements of StO 2 and DCS-based measurements of BFI were combined with S a O 2 and Hb obtained from arterial blood samples to yield baseline and hypercapnic CMRO 2i using equation (5) . Relative changes in OEF, BFI, and CMRO 2i in response to hypercapnia, i.e. %DOEF, %DBFI, and %DCMRO 2i , were computed using formulas analogous to equation (4) . Changes in StO 2 (DStO 2 ) were quantified as a difference between its hypercapnic and room air values.
Statistical Analysis
Paired Wilcoxon signed-rank tests were used to determine whether cerebral hemodynamic parameters during hypercapnia differed from baseline levels. Baseline MRI measurements of S v O 2 , CBF, and CMRO 2 , as well as relative and absolute changes during hypercapnia, were compared with optical measurements (StO 2 , BFI, and CMRO 2i ) using linear correlation by computing the Pearson's correlation coefficient. All analyses were performed using the R statistical package (Revolution Analytics), version 2.11; associated P values represent the significance of two-sided tests. 
RESULTS
Thirty-three patients were consented for this study. One patient was consented but not studied, thus the total cohort consisted of 32 patients; 13 had hypoplastic left heart syndrome, 13 had transposition of the great arteries, 1 had tricuspid atresia with ventricular septal defect and transposition of the great arteries, four had Tetralogy of Fallot, and one had aortic stenosis with arch hypoplasia and a ventricular septal defect. Table 1 lists the median and interquartile range values of the age, weight, gestational age, gender, and head circumference for the entire cohort (N ¼ 32). Patients were all full term and measurements were obtained at a median age of 4 days of life (range: 2 to 12 days). Figure 2 illustrates a sample time series of DOS and DCS data, i.e. DHbR, DHbO 2 , DTHC, and BFI as a function of time (Figures 2A  and 2B ). Figures 2C-2F Figures 2C and 2E) , and the increased contrast in the velocity maps ( Figures 2D and 2F ) indicate increased oxygenation level and blood flow velocity in response to hypercapnia.
The median (interquartile range) MRI-measured baseline OEF, S v O 2, CBF and CMRO 2 as well as DOS/DCS-measured baseline OEF, StO 2, BFI, CBV and CMRO 2i in the cohort are reported in Table 2 (StO 2 values in 14 babies from the present cohort were published previously in conjunction with a study evaluating postoperative changes in near-infrared spectroscopy parameters 16 ). Note substantial variation across subjects was observed among all measured resting-state variables. Median baseline CMRO 2 was 0.49 mL O 2 /minute per 100 g, but it ranged from a minimum of 0.28 to a maximum of 1.17 mL O 2 /minute per 100 g across the patient population. Interestingly, baseline CMRO 2 was highly linearly correlated with baseline CBF as measured by both MRI (R ¼ 0.70, Po0.001) and DOS/DCS (R ¼ 0.78, Po0.001).
The median increase in partial pressure of carbon dioxide during hypercapnia was 24.9 mm Hg (18.8, 31.2); commensurate with an increase in CBF and decrease in OEF, as measured by both MRI and optics (all Po0.001, Table 2 ). Cerebrovascular reactivity, i.e., the fractional change in CBF relative to the change in partial pressure of carbon dioxide, was measured by MRI to be 5.02 (3.13, 6.65) %/mm Hg and by DCS to be 3.01 (1.88, 3.94) %/mm Hg. Population-averaged changes in CMRO 2 during hypercapnia were not observed by MRI or by DOS/DCS (P ¼ 0.65, 0.70, respectively, Table 2 ). However, individual patients demonstrated a wide range of responses, showing both increases as large as 160% and decreases of as much as 80% in CMRO 2 .
As seen in Figure 3 and summarized in Table 3 Median and interquartile range of various hemodynamic parameters measured with MRI and optics at baseline and in response to hypercapnia. The P values were obtained from a Wilcoxon two-sided signed-rank test. *Determined from arterial blood gas analysis using co-oximetry.
Cerebral oxygen metabolism in neonates with CHD V Jain et al difference between the two modalities' measures of relative changes and the slope was not significantly different from zero. Correlations between the absolute changes in CBF and CMRO 2 compared with absolute changes in BFI and CMRO 2i were also computed ( Table 3) 
DISCUSSION
This work employs two novel noninvasive technologies, one based on MR and the other based on diffuse optics, to quantify cerebral oxygenation, perfusion, and CMRO 2 in a population of critically ill neonates with CHD undergoing cardiac surgery within the first month of life. The MR technique is sensitive to whole-brain macrovasculature, and the optical technique probes regional tissue microvasculature of the frontal cortex. Microvascular tissue oxygenation measures regional oxygen saturation whereas S v O 2 quantifies the oxygen saturation of the blood in the major draining vein. The latter, along with S a O 2 and a simultaneous measurement of CBF, provides the information needed to derive a global cerebral rate of oxygen consumption (CMRO 2 ). In recent years, several noninvasive MR-based methods for quantification of absolute CMRO 2 quantification have been introduced to evaluate regional or global cerebral metabolism. The regional voxel-based methods model the effect of deoxygenated Hb in the capillary/post capillary bed on MR-measured transverse relaxation T 2 to quantify the voxel-wise oxygen saturation, which can be combined with ASL CBF measurement to yield CMRO 2 . Among these are quantitative BOLD 9 and QUIXOTIC. 10 However, these methods involve complex models, are time intensive and numeric simulations and phantom experiments show that reliable estimates are achieved only in the presence of very high signal-to-noise ratio.
In contrast, methods that quantify oxygen extraction globally model the effect of deoxygenated Hb on the intravascular T 2 or MR signal phase of large veins to quantify intravascular S v O 2 , which combined with PC MR-based quantification of CBF, yield CMRO 2 . 11, 12, 25 Although these methods provide global rather than spatially resolved measures, they are robust, and allow much higher temporal resolution and CMRO 2 quantification in clinically feasible scan times. Recently proposed methods such as phase- Cerebral oxygen metabolism in neonates with CHD V Jain et al based regional oxygen metabolism 14 and T 2 relaxation under spin tagging (TRUST) 9 fall under this category. Our observations in anesthetized infants suggest that both MRI and optics-based techniques could be effectively integrated into future standard-of-care monitoring and management of critically ill neonates. Perhaps, most importantly, both techniques enable quantification of cerebral CMRO 2 , a parameter that is critical to our understanding of oxygen utilization in the brain, especially in neonates with CHD who grow in an oxygen-starved environment and can suffer subsequent neurologic injury as a result. Measurements of CMRO 2 can help develop and guide treatment to ensure optimal oxygen utilization of the brain. Overall, baseline CMRO 2 in our cohort (Table 2 ) was 80% lower than typically observed in healthy adults, for whom values were reported in the range from 2 to 4 mL O 2 /minute per 100 g. 13, 26, 27 Literature on CMRO 2 in neonates is scarce, due in part to the limited number of modalities available for use in very young children. In a study using PET in critically ill neonates from the neonatal intensive care unit, Altman et al 28 noted CMRO 2 values of 0.06 to 0.54 mL O 2 / 100 g per minute in preterm infants and 0.4 to 1.3 mL O 2 /100 g per minute in sick term infants. Thus, our baseline CMRO 2 values (Table 2 ) are lower than those in the sick neonates, but close to those observed in the preterm neonates who tend to have a high incidence of hypoxic-ischemic brain injury in the form of periventricular leukomalacia and are therefore somewhat similar to our term neonates with CHD.
Furthermore, using these MRI-and optics-based techniques, we quantified CBF, CBV, and cerebral tissue and venous oxygenation. Unlike CMRO 2 , which is very rarely quantified in infants, the former parameters are cited in literature more often; however, the techniques used to quantify these parameters are typically invasive, employing arterial or venous blood draws or the use of radioactive tracers. We observed a median resting-state CBF of 9.58 mL/minute per 100 gB20% of normal adult CBF, which is typically around 50 mL/minute per 100 g, 13, 26, 27 and B30% to 50% of healthy neonatal CBF in the frontal cortex, which Chiron et al reported as 34±3.5 mL/minute per 100 g (using SPECT with 133 Xe) and Miranda et al. reported as 16.6 ± 5.9 mL/minute per 100 g (using arterial spin labeled perfusion MRI, ASL pMRI). 29, 30 Licht et al 7 measured CBF with ASL perfusion MRI in a similar population of 25 term infants with CHD, found average resting CBF of 19.73 ± 9.15 mL/minute per 100 g, or approximately twice our current reported values. It bears mentioning that ASL pMRI has low intrinsic signal-to-noise ratio, 31,32 a problem that is exacerbated in very low-flow states, which is why ASL pMRI was not employed in this study. 31, 33 The problem is further aggravated at 1.5T preventing accurate ASL measurements of CBF. Our current CBF values are more similar to those of preterm infants, which Pryds et al 34 reported as 10 ± 4 mL/minute per 100 g in a cohort of preterm neonates with a mean gestational age of 30.2 ± 2.8 weeks using intravenous 133 Xe clearance. 30, 34 Similarly, we observed a median cerebral blood volume of 1.74 mL/100 g in our cohort, which is substantially lower than the cerebral blood volume measured by Ijichi et al. 22 using near-infrared spectroscopy in term neonates, although it is closer to the cerebral blood volumes they measured in preterm infants at 30 to 32 weeks postconceptual age.
Owing to a lack of longitudinal measurements in this CHD population, it is not possible to determine if the low CBF measures are secondary to low demand (low CMRO 2 ) or conversely, whether the low demand is a consequence of low oxygen delivery during brain development. Studies comparing CHD infants to other term infants without CHD include an MR spectroscopy study, which revealed striking structural and biochemical immaturity of the white matter in infants with CHD. 35 Licht et al 36 used a semiquantitative observational scale to compare the maturation patterns seen in anatomic brain MRIs and demonstrated that the brain structures in infants with CHD were similar to preterm infants born at 35 weeks of gestation. In addition, Limperopoulos et al 37 used fetal MRI data to demonstrate a lag in brain growth during the third trimester of fetal development. We posit that the apparent delay in cerebral maturation is due to the alteration in fetal oxygen delivery to the brain that occurs as a consequence of the CHD anatomy. Taken together, our data suggest that CBV, CBF, and CMRO 2 in term infants with CHD are closer to the values obtained in preterm than healthy term infants.
Consistent with the known vasodilatory effects of CO 2 , we observed an increase in CBF with hypercapnia (Po0.001; Table 2 ), suggesting that CO 2 reactivity is intact in this cohort. Global CMRO 2 measured with both MRI and DOS/DCS showed no population-averaged change due to hypercapnia. This observation agrees with our previous experience in healthy adults 20 and with several other publications that examined cerebrovascular reactivity to hypercapnia in patients with congenital heart defects using localized measurement techniques, such as DOS and DCS. 15, 24, 38 In addition to generating new physiologic data, this work also achieved several technical goals. First, it demonstrates the feasibility of a combined MRI-susceptometry and phase-contrast method to measure S v O 2 , CBF and CMRO 2, in neonates with complex CHD, all in absolute physiologic units. Second, the absolute normocapnic MRI measurements were tightly correlated with optical DOS/DCS indices of regional blood flow and CMRO 2 . Transport to MRI is not always feasible, e.g., a neonate with hemodynamic instability or dependent on technologies such as an external pacemaker or extracorporeal membrane oxygenation. Therefore, the strong correlations of MRI and optical methods provide useful new calibration factors for optical techniques in this patient group, and they suggest that DOS/DCS may prove valuable as a portable bedside monitor to assess cerebral perfusion and oxygen utilization. We note that the calibration factors derived are strictly valid only for the specific population studied and thus studies in related (e.g., healthy age-matched) populations will be needed. The present work illustrates how such measurements should be carried out and provides a useful point of comparison for future measurements in related populations. Furthermore, many similarities exist between the normal and diseased populations that might not change with disease from the standpoint of the optical measurements, e.g., head geometry, average tissue absorption, and scattering, etc. For this reason, the calibrations presented may offer a useful 'first' approximation for related populations.
Interestingly, the correlations observed between MRI and optical methods were strong even though the techniques have different spatial and physiologic sensitivities. For example, MRIsusceptometry measures venous oxygenation (S v O 2 ) whereas DOS measures regional tissue microvasculature oxygenation (StO 2 ), which is a weighted average of arterial, capillary, and venous oxygenation levels. Additionally, the optical BFI depends on the motion and concentration of red blood cells and is thus a surrogate measure of regional CBF in the microvasculature of the frontal cortex; by contrast, the MRI-measured CBF derives its macrovascular signal from the draining veins of the whole brain, with bias to the cortical mantle.
Notwithstanding these differences, the correlations between baseline S v O 2 and StO 2 , and baseline CBF and BFI were robust (Figure 3) . Perhaps, somewhat surprisingly, the values of S v O 2 were higher or equal to the StO 2 . One might expect S v O 2 to be lower than StO 2 , as the latter has an arterial contribution. However, some discordance between the two measurements might also be expected, because the optical probe measures focal hemodynamics over the frontal areas of the brain, which tend to be hypometabolic in neonates. 39 Finally, the measured values of StO 2 agree very well with those previously reported by Kurth et al 40 in nonanesthetized CHD infants.
Furthermore, although correlation between relative changes in CBF and BFI due to hypercapnia was highly significant (R 2 ¼ 0.67, Po0.001), the optically measured %DBFI tended to underestimate the MRI-measured %DCBF. This underestimation is potentially due to the regional heterogeneity in cortical cerebrovascular response to hypercapnia. 41 In adults, cerebrovascular reactivity among frontal, parietal, temporal, and occipital cortices has been measured to vary substantially; 41 thus, changes in frontal cortex CBF measured with DCS need not correlate in a 1:1 fashion with changes in global venous flow in the SSS measured with MRI. Alternatively and/or additionally, the underestimation of %DBFI compared with %DCBF may be due to the effects of extracerebral layers on the DCS signal. One might expect, however, that at large, source-detector separations and for hypercapnic functional perturbations, the changes measured by diffuse optics should be mostly occurring in the deeper tissues and should therefore be least susceptible (i.e. compared with baseline measurements) to be different from changes observed by MRI.
Limitations
One obvious limitation of our study is the lack of healthy control subjects. Nevertheless, both MRI and optical techniques can readily be employed in healthy neonates, and recruitment of agematched healthy neonates will be the subject of future studies. Furthermore, anesthetic effects could mask true resting-state values of cerebral hemodynamics in our CHD cohort. However, sedation and paralysis were achieved with fentanyl and pancuronium, both of which have been demonstrated to have minimal effects of CBF and CMRO 2 in animal models. [42] [43] [44] Although our initial experience with MRI-and optics-based CMRO 2 quantification in neonates with complex CHD has been encouraging, each technique presents its own limitations. We discuss limitations with the MRI technique first. The accuracy of MRI-measured S v O 2 quantification depends on Dw do , which has been previously determined using healthy adult blood. 17, 45 It is plausible that this constant might differ slightly for fetal blood given the presence of fetal Hb. However, it is unlikely that the inherent paramagnetism of heme iron in its deoxy state in fetal Hb is substantially different from that in adult Hb as the two Hb types differ only in the type of globin chains present. Good agreement with optical data (Figures 3 and 4) gives us confidence that these sorts of corrections, i.e. due to potential differences in magnetic properties of fetal Hb, are small. In a different vein, the S v O 2 , CBF, and CMRO 2 measurements presented herein still require arterial blood samples. However, even though pulse oximetry offers a noninvasive measure of peripheral oxygen saturation as a possible alternative to blood gas analysis, for this cohort of cyanotic neonates, pulse oximetry measures are also subject to errors. Blood flow in the SSS, which drains only the cortical mantle, was used to determine total CBF, based on recent work showing that the SSS accounts for 45% of total CBF as pointed out earlier. 19 Finally, the MRI measurements require transport and are not amenable to bedside monitoring; however, once in-magnet, the pulse sequences employed permit rapid quantification of cerebral hemodynamics (o5 minutes including localizer scans) and can be conveniently added to standard clinical protocols without additional time penalties.
The diffuse optical spectroscopies have limitations as well. Generally, the optical methods are limited to probing shallow depths in the frontal cortex in the region under the optical probe. In this study, we presumed and corroborated that diffuse optical frontal cortex measurements produce physiologic parameters that are indicative of whole-brain resting state and hypercapnic responses (e.g., as measured by MRI). In general, this assumption may not be true, e.g., in disease states such as stroke or hemorrhage; in addition, the study of regional responses is interesting in its own right. Further, as mentioned above, in studies of human brain, optical techniques are also sensitive to the responses of extracerebral tissues such as scalp and skull. To alleviate the potential issues of extracerebral signal contamination, two-and multilayer analysis models can be employed, and physical perturbations such as increased probe pressure can be used to maximize cerebral signals; this problem is an issue of current research interest. Finally, the blood flow indices are not absolute. Again, however, studies such as the present one offer a means to calibrate DCS indices in particular patient populations and, of course, functional activation and/or perturbation responses do not require absolute indices.
CONCLUSION
In summary, using MRI and optical techniques, we noninvasively quantified suppressed cerebral oxygenation, flow, and CMRO 2 in neonates with complex CHD as compared with literature values for controls. The findings of strikingly low CBF and CMRO 2 are in keeping with the observations made by this group and others, i.e. the brains of term infants with severe forms of CHD are immature and more similar to the brains of premature infants. Furthermore, we confirmed CO 2 reactivity in these patients is intact, and we observed significant correlations between MRI-measured S v O 2 , CBF, and CMRO 2 with optical measurements (StO 2 , BFI, CMRO 2i ) both at rest and during hypercapnia. These results suggest MRI and optical measurements of cerebral hemodynamics parallel one another for evaluation and management of critically ill CHD neonates.
DISCLOSURE/CONFLICT OF INTEREST
The authors declare no conflict of interest.
